dr. lebbe discusses efficacy of avelumab in merkel cell carcinoma
Published 6 years ago • 215 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:06
managing avelumab side effects in patients with merkel cell carcinoma
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
0:35
dr. kudchadkar on the fda approval of avelumab in merkel cell carcinoma
-
0:42
dr. kudchadkar on immunotherapy in merkel cell carcinoma
-
2:18
durable responses to avelumab in patients with merkel cell carcinoma
-
1:03
role of immunotherapy in merkel cell carcinoma
-
1:09
dr. apolo on updated javelin results of avelumab in urothelial carcinoma
-
1:18
dr. nghiem on challenges with immunotherapy in merkel cell carcinoma
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
1:28
avelumab treatment in patients with metastatic merkel cell carcinoma
-
1:19
dr. nghiem on response to immunotherapy in merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
1:34
javelin merkel 200: avelumab for metastatic merkel cell carcinoma
-
1:37
dr. kaufman discusses durable responses to avelumab in merkel cell carcinoma
-
0:38
dr. siefker-radtke on fda approval of avelumab in bladder cancer
-
1:37
avelumab for treatment of metastatic merkel cell carcinoma
-
5:55
targetting pd-l1 with avelumab in metastatic merkel cell carcinoma
-
1:42
dr. hamid on the fda approval of pembrolizumab in merkel cell carcinoma
-
2:19
chemotherapy vs. immunotherapy for the treatment of merkel cell carcinoma